Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,101–3,125 of 7,816 matching trials · page 125 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
The Senior Companion Program Plus NCT03602391 SCP Plus Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | The University of Texas at Arlington OTHER |
2024-10-01 |
|
Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of Dementia NCT03638284 Transcranial Direct Current Stimulation Runs in: Canada · 1 site |
NA other |
COMPLETED | 13 | Centre for Addiction and Mental Health OTHER |
2024-10-01 |
|
High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease NCT04042922 GENUS device (Active Settings); GENUS device (Sham Settings) Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 80 | Massachusetts Institute of Technology OTHER |
2024-10-01 |
|
Feasibility of the Mindfulness-Based Stress Reduction Intervention for Black Women Living With HIV Supplement NCT04984681 Mindfulness; Usual Care Runs in: United States · 1 site |
NA other |
COMPLETED | 30 | University of Alabama at Birmingham OTHER |
2024-10-01 |
|
REducing the Risk of COgnitive DEcline ad Dementia in Patients With Subjective Cognitive Decline Through an Immersive Virtual Reality and Telemedicine-based Multi-component Intervention: the SCD-ReCODED Study NCT06429215 Multi-component Intervention (MC-I): VR Cognitive training and Psyc... Runs in: Italy · 1 site |
NA other |
RECRUITING | 75 | I.R.C.C.S. Fondazione Santa Lucia OTHER |
2024-10-01 |
|
Mindfulness-Based Intervention Using Consumer-Grade Wearable Devices with Biofeedback for Family Caregivers of People with Dementia NCT06619938 Mindfulness With Biofeedback; Mindfulness Without Biofeedback |
NA other |
NOT_YET_RECRUITING | 260 | The Hong Kong Polytechnic University OTHER |
2024-10-01 |
|
Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients NCT06620393 Dexmedetomidine; Placebo |
PHASE2|PHASE3 other |
NOT_YET_RECRUITING | 72 | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal OTHER |
2024-10-01 |
|
A Study Evaluating the Efficiency and Safety for the VGuard Device in Alzheimer's Disease. NCT06620640 Intervention will most probably modify activity of neuron networks ... Runs in: Poland · 1 site |
NA other |
COMPLETED | 105 | Neuromedical Sp. z o.o. INDUSTRY |
2024-10-01 |
|
Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD NCT06621758 questionnaire |
NA other |
NOT_YET_RECRUITING | 120 | Danish Dementia Research Centre NETWORK |
2024-10-01 |
|
TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease NCT03539380 TRx0237 |
NA other |
AVAILABLE | — | TauRx Therapeutics Ltd INDUSTRY |
2024-09-27 |
|
Effect of Astaxanthin on the Patients With Alzheimer Disease NCT05015374 Astaxanthin; Placebo Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 46 | Kaohsiung Medical University Chung-Ho Memorial Hospital OTHER |
2024-09-27 |
|
Impact of EsTOCma on OCD Family Members NCT06616350 esTOCma: an app to fight stigma associated with OCD Runs in: Spain · 1 site |
NA other |
COMPLETED | 211 | University of Valencia OTHER |
2024-09-27 |
|
Gamma-Induction in FrontoTemporal Dementia Trial NCT04425148 Transcranial Alternating Current Stimulation (tACS); Sham Transcran... Runs in: Italy; United States · 2 sites |
NA other |
UNKNOWN | 70 | Massachusetts General Hospital OTHER |
2024-09-26 |
|
The Peace of Mind and Body Project: Treatment Development of Yoga for Anger Management in Incarcerated Adults NCT05336123 Hatha Yoga; Health Education Runs in: United States · 1 site |
NA other |
COMPLETED | 40 | Brown University OTHER |
2024-09-26 |
|
Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders NCT06615167 ALZGUARD Runs in: South Korea · 3 sites |
NA other |
RECRUITING | 122 | HAII corp.ltd INDUSTRY |
2024-09-26 |
|
Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia NCT02675270 Phonological; Orthographic; Semantic; Lexical; Untrained Runs in: United States · 2 sites |
NA other |
COMPLETED | 84 | Georgetown University OTHER |
2024-09-25 |
|
Effect of "breath of Fresh Air" Flash Activity on Dementia Agitation : Pilot Study NCT04094779 Usual relation care; Flash activity "breath of fresh air" Runs in: France · 1 site |
NA other |
COMPLETED | 28 | University Hospital, Toulouse OTHER |
2024-09-25 |
|
Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease NCT04643327 Levetiracetam; Placebo Runs in: Australia · 1 site |
PHASE2 other |
RECRUITING | 28 | The University of Queensland OTHER |
2024-09-25 |
|
A Study of Semorinemab in Patients With Moderate Alzheimer's Disease NCT03828747 Semorinemab; Placebo; [18F]GTP1 Runs in: France; Poland; Spain; United States · 49 sites |
PHASE2 anti-tau |
COMPLETED | 272 | Genentech, Inc. INDUSTRY |
2024-09-24 |
|
Enhancing Mobility and Mental Health in Dementia Patients NCT06611202 Exercise; Clonazepam Runs in: United Kingdom · 1 site |
NA other |
NOT_YET_RECRUITING | 6 | Oxleas NHS Foundation Trust OTHER |
2024-09-24 |
|
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia NCT00792662 Methylphenidate; Placebo |
PHASE4 other |
WITHDRAWN | 0 | University of Nebraska OTHER |
2024-09-23 |
|
Memory and Social Interactions NCT05800028 Learning new information Runs in: France · 1 site |
NA other |
RECRUITING | 192 | University Hospital, Caen OTHER |
2024-09-20 |
|
Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders NCT01459302 Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | University of Massachusetts, Worcester OTHER |
2024-09-19 |
|
Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease NCT02380573 Methylene Blue; FD&C Blue # 2; Phenazopyridine hydrochloride Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 117 | The University of Texas Health Science Center at San Antonio OTHER |
2024-09-19 |
|
Communication Bridge Speech Therapy Research Study NCT02439853 Monthly Check-in Session Runs in: United States · 1 site |
NA other |
COMPLETED | 57 | University of Chicago OTHER |
2024-09-19 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial